A broken promise: microbiome differential abundance methods do not control the false discovery rate

Stijn Hawinkel, Federico Mattiello, Luc Bijnens, +1

Briefings in Bioinformatics

Nonparametric SimulationHigh Throughput SequencingMicrobial EcologyBiostatisticsEnvironmental Microbiology +14

Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study

Bruce D. Cheson, Neil Chua, Greg Dueck, +13

Journal of Clinical Oncology

Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL

Magdalena Klánová, Laurie H. Sehn, Isabelle Bence‐Bruckler, +16

Blood

A web application for sample size and power calculation in case-control microbiome studies

Federico Mattiello, Bie Verbist, Karoline Faust, +4

Bioinformatics

End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA

Lale Kostakoglu, Maurizio Martelli, Laurie H. Sehn, +16

Blood Advances

Oncologic ImagingPet-mriPathologyFirst-line TreatmentPositron Emission Tomography +14

Obinutuzumab plus Bendamustine Followed by Obinutuzumab Maintenance Prolongs Overall Survival Compared with Bendamustine Alone in Patients with Rituximab-Refractory Indolent Non-Hodgkin Lymphoma: Updated Results of the GADOLIN Study

Bruce D. Cheson, Marek Trněný, Kamal Bouabdallah, +9

Blood

Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study

Lale Kostakoglu, Federico Mattiello, Maurizio Martelli, +16

Haematologica

Follicular Lymphoma Evaluation Index (<scp>FLEX</scp>): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy

Farheen Mir, Federico Mattiello, Andrew Grigg, +8

American Journal of Hematology

Cancer ManagementPrognosisImmunologyPathologyImmunotherapy +15

Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma

Christopher R. Bolen, Federico Mattiello, Michael Herold, +10

Blood

Lymphoid NeoplasiaTreatment DependenceMedicineImmunologyFollicular Lymphoma +9

An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphoma

James Normington, Jiawen Zhu, Federico Mattiello, +2

Contemporary Clinical Trials

Bayesian StatisticHistorical Control DataUncertainty QuantificationBiostatisticsStatistical Inference +4